Skip to main content
. 2022 Oct 14;19(20):13280. doi: 10.3390/ijerph192013280

Table 2.

Summary of studies investigating new-onset hypertension after COVID-19 recovery.

Reference Country Study Type Sample Size Follow-Up Timeframe Results
Akpek, M. [14] Turkey Retrospective cohort study 153 One-month Systolic Blood Pressure [mmHg] mean ± (interquartile range) (p < 0.001)

  • On admission 120.9 ± (113.7; 128.1);

  • Post-COVID-19 126.5 ± (111.5; 141.5)

Diastolic Blood Pressure, [mmHg] mean ± (interquartile range) (p < 0.001)

  • On admission 78.5 ± (74.1; 82.9)

  • Post-COVID-19 81.8 ± (74.4; 89.2)
De Lorenzo, R. et al. [15] Italy Retrospective and prospective cohort study 185 Twenty-three days Systolic Blood Pressure [mm Hg] median (interquartile range) p = 0.17

  • All Cohort n = 185: 132.5 (123; 144.8);

  • Discharged from ED n = 59: 130 (120;141);

  • Hospitalized n =126: 134 (125;145);

Diastolic Blood Pressure, [mmHg] median (interquartile range) p = 0.99

  • All Cohort n = 185: 70 (70; 85)

  • Discharged from ED n = 59: 70 (70; 86);

  • Hospitalized n =126: 80 (70; 85).
Gameil, M.A. et al. [16] Egypt Case-control study 120 Three months Systolic Blood Pressure [mm Hg] mean ± SD p = 0.001

  • COVID-19 survivors 126.70 ± 10.31;

  • Control group 120.63 ± 8.49.

Diastolic Blood Pressure, [mmHg] mean ± SD p = 0.08

  • COVID-19 survivors 79.94 ± 7.32;

  • Control group 77.86 ± 7.05.
Nesan, G. et al. [11] India Longitudinal study 354 Three months 5 individuals developed hypertension: 4 (80%) females and 1 (20%) male; p = 0.002.

COVID-19, coronavirus disease 2019; ED, emergency department; n, sample size; p, p-value; SD, standard deviation.